Navigation Links
ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)
Date:1/26/2009

LEUVEN, Belgium and LUND, Sweden, January 26 /PRNewswire-FirstCall/ -- ThromboGenics NV (EURONEXT:THR) and BioInvent International AB (OMXS:BINV) announce today that they have received a technology transfer success fee of EUR5 million from Roche under the terms of their strategic alliance for the novel anti-cancer antibody, TB-403. The payment has been triggered by the successful transfer and implementation of technology and process development to Roche in relation to the ongoing clinical development of TB-403.

The TB-403 strategic alliance with Roche was signed in June 2008. Under the terms of this ongoing agreement, ThromboGenics and BioInvent received an initial upfront payment of EUR50 million, with the potential of milestone payments of up to EUR450 million following completion of a series of development and commercial milestones, as well as double digit royalties on future sales. ThromboGenics, which discovered TB-403, receives 60% and BioInvent 40% of the revenue from the deal.

Under the terms of the agreement, Roche is responsible for all development costs for TB-403, including the completion of the Phase Ib trial currently being run by BioInvent and ThromboGenics.

TB-403 (anti-PlGF) is a humanized monoclonal antibody that blocks the formation of the new blood vessels required by solid tumours to support growth. PlGF is a homologue of VEGF, and clinical evidence suggests that it plays a role in the angiogenesis of malignant tissue, and does not affect normal tissue angiogenesis.

Patrik De Haes, CEO of ThromboGenics, commented, "We are very pleased to be able to make this announcement today. The fact that we have been able to achieve the goal that has triggered this payment from Roche so quickly highlights the excellent working relationship that has developed between all parties in this important strategic alliance. We are looking forward to the results of the current Ph
'/>"/>

SOURCE ThromboGenics NV
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease
2. ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin
3. ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
4. PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications
5. Kiadis Pharma Receives Two Orphan Drug Designations for Reviroc(TM) From the FDA
6. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
7. PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.
8. Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union
9. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
10. Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors
11. Abbott Receives Complete Response Letter From FDA for Controlled-Release Hydrocodone With Acetaminophen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Decision Resources Group ... the Memphis health system and ... clinical integration, with rivals Methodist Le Bonheur Healthcare and ... groups to coordinate patient care. In addition, a national ... the most health plan enrollment in the ...
(Date:8/27/2014)... 2014 ResearchMoz presents this most ... Market Outlook to 2020. New report, "United States Laparoscopes ... the United States Laparoscopes market . The report ... units) and average prices (in US dollars) within market ... Tip Video Laparoscopes), Robotic Surgical Systems and Rigid Tip ...
(Date:8/27/2014)... WASHINGTON , Aug. 27, 2014 An experimental ... promise as a viable first treatment for anemia of inflammation, ... of the treatment published online today in Blood ... Hematology (ASH).    Anemia is a condition ... or do not function properly. When an individual has anemia, ...
Breaking Medicine Technology:Memphis-area Health Systems Turn Attention to Clinical Integration 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3
... 11 BioStorage Technologies, a global leader in ... for the pharmaceutical and biotechnology industries, has expanded ... preparation services, including sample aliquoting and nucleic acid ... for comprehensive sample management continues to grow, BioStorage ...
... Oct. 11 CEL-SCI Corp. (Amex: CVM ) ... Virtual ConferenceWhen: , October 13, 2010 @ 11:30 AM ... the Internet -- Simply log on to the web at ... If you are unable to participate during the live webcast, ...
Cached Medicine Technology:Industry Leader BioStorage Technologies Broadens Sample Management Operations to Include Laboratory Sample Preparation Services 2
(Date:8/28/2014)... 28, 2014 Now in its 4th year, ... started in 2011 by two brain aneurysm survivors. The ongoing ... awareness, provide education to help increase early detection and to ... a brain aneurysm. We hope that you will be able ... at the 4th Annual Step for Hope Run/ Walk on ...
(Date:8/28/2014)... MMAR Medical is pleased to announce their ... regular customers to enjoy several perks and benefits when ... wholesale license. It’s a great choice for independent athletes, ... who regularly purchase medical braces but could use a ... active lifestyle or those of your club, group or ...
(Date:8/28/2014)... 28, 2014 The revenue cycle process ... from the time a patient books an appointment with ... provide final payments for services rendered to the healthcare ... billing service has the RCM process down to a ... computers become common place in nearly every healthcare facility ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 UniVoIP, Inc, ... El Segundo, CA, today announced that they have been ... of Los Angeles Local Small Business Enterprise (Local SBE) ... and certified by the state of California and LA ... Cloud-hosted Telephony Solution to governmental agencies throughout ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 Author and ... iUniverse) takes readers on the thrilling adventures of sharp ... published in 2012, is gearing up for a new ... Split into two novellas , “Prescription: Murder” follows ... who finds himself dodging assassination attempts and thwarting criminals. ...
Breaking Medicine News(10 mins):Health News:Step for Hope and Raise Brain Aneurysm Awareness 2Health News:MMAR Medical Announces Customer Membership Program 2Health News:Tips on Automating the Revenue Cycle Process with Medical Billing 2Health News:Tips on Automating the Revenue Cycle Process with Medical Billing 3Health News:Cloud PBX Provider UniVoIP Gets Certified by the State of California and the County of Los Angeles Under the Local Small Business Enterprise (SBE) Preference Program 2Health News:William H. Simon Launches New Marketing Campaign for Book 2
... the brain called the choroid plexus that ostensibly possesses ... protein, associated with Alzheimer’s disease.// ,The ... protein, called beta-amyloid, and prevents it from accumulating in ... cord. Wei Zheng, an associate professor in the School ...
... a recent research, Angina, a from of heart disease that ... the fair sex//. Angina can cause heart attacks. ,Angina ... triggered by deficiency in oxygen that is carried to the ... narrowing of coronary arteries. Exercise, cold or emotional stress can ...
... on the newer medications for diabetics had a slightly ... and $1,760 less on annual total healthcare costs. ... the Merrell Dow professor of pharmacy at Ohio State ... data on patients who took thiazolidinediones (TZDs) or either ...
... breast cancer found a savior in her daughter, who helped ... Herceptin could be made available for her to fight debilitating ... the cancer drug to Mrs. Morgan, of Whitchurch. Katie Morgan, ... Owen Paterson, and expressed her mother’s condition, petitioning for humanitarian ...
... one of the deadliest diseases in UK. Symptoms include a ... to rush to the loo//. ,Hence DUP MP ... awareness about prostate cancer. Prostate cancer kills 220 men in ... ,Mr Campbell has won the support of 55 ...
... to sleep more and more and just can’t seem to ... the University of Athens//, one among four adults and one ... of snooze time every night. ,Psychiatry professor and head ... “We spend 20 percent less time sleeping now than 100 ...
Cached Medicine News:Health News:Angina Risks Pronounced In Women over 45 2Health News:New Diabetic Drugs More Effective than Older Ones 2
The perfect quick consult for the busy cardiologist, The Ultimate Echo Guide puts the most clinically essential information in an easy access format....
... a quick-lookup reference for ECG interpretation ... presents the basics (anatomy and physiology ... system of the heart, basic ECG ... algorithms, emergency medications, and comprehensive information ...
Dx/Rx: Heart Failure has tables and figures that summarize important clinical data and current professional society recommendations and up-to-date information for diagnosis and treatment of Heart Fai...
Topics include: ECG reading, ACLS (all the latest protocols and pearls), CHF, acute MI, cardiac testing, palpitations, pericarditis, arrhythmias, murmurs, athletes, valvular disease, endocarditis, sy...
Medicine Products: